Cabot (FRA:CBT) Other Long-Term Liabilities: €210 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CBT Cabot Corp FRA:CBT
82 GF Score
Price €67.10
GF Value €70.41
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cabot Other Long-Term Liabilities?

Cabot FRA:CBT -0.59% 82 Other Long-Term Liabilities is €210 Mil as of Jun. 2026. GuruFocus rates FRA:CBT with a GF Score™ of 82/100 and a GF Value™ of €70.41 (Fairly Valued). The stock has 3 warning signs investors should review.

Cabot's other long-term liabilities for the quarter that ended in Jun. 2026 was €210 Mil.

Cabot's quarterly other long-term liabilities declined from Dec. 2025 (€219 Mil) to Mar. 2026 (€207 Mil) but then increased from Mar. 2026 (€207 Mil) to Jun. 2026 (€210 Mil).

Cabot's annual other long-term liabilities increased from Sep. 2023 (€93 Mil) to Sep. 2024 (€95 Mil) and increased from Sep. 2024 (€95 Mil) to Sep. 2025 (€106 Mil).

Cabot Other Long-Term Liabilities Related Terms

Cabot Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Cabot's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabot Other Long-Term Liabilities Chart

Cabot Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.75 101.00 92.76 94.61 105.65

Cabot Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 233.22 105.65 219.48 206.74 210.06
FRA:CBT
82GF Score
Cabot Corp FRA:CBT
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabot Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €210 Mil mean?
Cabot (FRA:CBT) has a Other Long-Term Liabilities of €210 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cabot and its competitors.
Is Cabot's Other Long-Term Liabilities too high?
Cabot's current Other Long-Term Liabilities is €210 Mil. Overall, Cabot has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cabot's Other Long-Term Liabilities compare to CLMT and AVNT?
Cabot's Other Long-Term Liabilities of €210 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Chemicals company?
A good Other Long-Term Liabilities depends on the Chemicals industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cabot and its competitors. Cabot's current Other Long-Term Liabilities is €210 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (FRA:CBT) is currently considered Fairly Valued. The stock's GF Value™ is €70.41, compared to a current price of €67.10 — trading 4.7% below its estimated fair value. The current Other Long-Term Liabilities is €210 Mil. Cabot's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Cabot (FRA:CBT), the current Other Long-Term Liabilities is €210 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabot (FRA:CBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cabot stock appears to be undervalued. The current stock price of €67.10 is trading 4.7% below its estimated GF Value™ of €70.41. GuruFocus considers Cabot to be Fairly Valued.

Key valuation signals for FRA:CBT:

  • Other Long-Term Liabilities: €210 Mil
  • GF Value™: €70.41 vs. price of €67.10 (4.7% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the FRA:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabot Business Description

Other Exchanges CBT:USACBT:Germany
Address Two Seaport Lane, Suite 1400, Boston, MA, USA, 02210
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
82GF Score

Get the complete analysis for FRA:CBT

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€67.10
Price
€70.41
GF Value